James Allison

Dr. James Allison earned the 2018 Nobel Prize in Physiology or Medicine, which he shared with Dr. Tasuku Honjo, “for their discovery of cancer therapy by inhibition of negative immune regulation.” He is the Executive Director of the Immunotherapy Platform at MD Anderson Cancer Center in Houston, Texas. Dr. Allison studies the regulation of T cell responses and developing strategies for cancer immunotherapy. His research led to the development of the first immune checkpoint blockade therapy approved by the FDA.